Comparison of the antihypertensive effects and safety of pinacidil and captopril

R. Buoninconti, V. Cagli, A. Bossini, C. Di Veroli, R. De Cesaris, G. Ranieri, A. Rappelli, P. Dessi Fulgheri

Research output: Contribution to journalArticlepeer-review

Abstract

To compare the antihypertensive efficacy and safety of pinacidil in mild to moderate essential hypertension with that of captopril, 128 patients (63 men and 65 women), mean age 50.49 ± 0.71 years, were treated in a controlled study lasting 10 weeks. The initial dosage (pinacidil: 12.5 mg BID; captopril: 25 mg BID) could be doubled (25 mg BID and 50 mg BID, respectively) or combined with hydrochlorothiazide (12.5 mg BID) at fixed times during the study, whenever diastolic blood pressure remained >95 mmHg. Normalization of blood pressure was reported for 67.2% of patients treated with pinacidil and 68.7% of those treated with captopril. The captopril group required the diuretic combination more frequently. Heart rate, body weight, and laboratory parameters did not show clinically important changes during either treatment. No side effects were observed in 86% of patients treated with pinacidil and in 89% of those treated with captopril.

Original languageEnglish
Pages (from-to)638-647
Number of pages10
JournalCurrent Therapeutic Research
Volume53
Issue number6
DOIs
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Comparison of the antihypertensive effects and safety of pinacidil and captopril'. Together they form a unique fingerprint.

Cite this